Results from the photon cohort of NRG-BN001, a signal seeking Phase II randomized trial, has delivered hope to patients battling glioblastoma, one of the most aggressive brain tumors, suggesting that…
Ten percent higher 5-year overall survival rates in patients receiving precise proton therapy vs. traditional radiation therapy Patients had significantly fewer side effects and improved quality of life, including less…
Last fall, experts from across the country gathered at the NAPT Research Forum in Washington, D.C. to discuss one of the most pressing issues in cancer care today: how to…
The National Association for Proton Therapy (NAPT) was proud to host the The Power of Protons: Accelerating Access and Innovation in Cancer Care on October 23, 2025, at MOCA Jacksonville, in…
Shannon M MacDonald, FASTRO, FACRO Southwest Florida Proton Center Introduction Radiotherapy has long played a significant curative role in the management of breast cancer. Proton therapy, an advanced form…
GUEST CONTRIBUTORS: Chrissy Rubin, LCSW, Lead Social Worker Mark Eala, LMSW, Social Worker New York Proton Center As oncology professionals, we know that a…
GUEST CONTRIBUTOR: Corrie T. M. Anderson, M.D., FAAP Professor, Anesthesiology and Pain Medicine Professor of Pediatrics (adj) University of Washington | Seattle Children’s …
GUEST CONTRIBUTOR: Lotte van der Werf MSc Global Health PhD Candidate Implementation of Value Based Healthcare & Jr. Project Coordinator, Maastro Clinic, the Netherlands [minti_divider style="3" margin="40px…
As we follow the actions of the new presidential administration and await more announcements about healthcare leadership and cancer research initiatives, it’s a good time to reflect on the past…
NAPT Advocacy Report: 2024 Throughout 2024, the National Association for Proton Therapy (NAPT) continued to amplify its advocacy efforts and health policy initiatives. These efforts aligned with NAPT’s mission to…
